Author's Reply: Methodological Considerations to Enhance the Relevance of Causal Observational Research in the Field of Kidney Disease.
作者信息
Cheng Franco Wing Tak, Xu Wanchun, Tang Sydney Chi Wai, Wan Eric Yuk Fai
机构信息
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Pharmacy Department, Gleneagles Hong Kong Hospital, Hong Kong SAR, China.
出版信息
J Am Soc Nephrol. 2025 May 1;36(5):989-990. doi: 10.1681/ASN.0000000661. Epub 2025 Mar 13.
Abstract
摘要
相似文献
1
Author's Reply: Methodological Considerations to Enhance the Relevance of Causal Observational Research in the Field of Kidney Disease.作者回复：提高因果观察性研究在肾脏疾病领域相关性的方法学考量
J Am Soc Nephrol. 2025 May 1;36(5):989-990. doi: 10.1681/ASN.0000000661. Epub 2025 Mar 13.
2
Methodological Considerations to Enhance the Relevance of Causal Observational Research in the Field of Kidney Disease.提高因果观察性研究在肾脏疾病领域相关性的方法学考量
J Am Soc Nephrol. 2025 May 1;36(5):988. doi: 10.1681/ASN.0000000660. Epub 2025 Mar 13.
3
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾脏病患者的HMG辅酶A还原酶抑制剂（他汀类药物）
Cochrane Database Syst Rev. 2023 Nov 29;11(11):CD007784. doi: 10.1002/14651858.CD007784.pub3.
4
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾病患者的HMG辅酶A还原酶抑制剂（他汀类药物）
Cochrane Database Syst Rev. 2014 May 31(5):CD007784. doi: 10.1002/14651858.CD007784.pub2.
5
HMG CoA reductase inhibitors (statins) for kidney transplant recipients.肾移植受者使用的HMG CoA还原酶抑制剂（他汀类药物）
Cochrane Database Syst Rev. 2014 Jan 28;2014(1):CD005019. doi: 10.1002/14651858.CD005019.pub4.
6
HMG CoA reductase inhibitors (statins) for dialysis patients.用于透析患者的HMG CoA还原酶抑制剂（他汀类药物）。
Cochrane Database Syst Rev. 2013 Sep 11;2013(9):CD004289. doi: 10.1002/14651858.CD004289.pub5.
7
HMG CoA reductase inhibitors (statins) for kidney transplant recipients.用于肾移植受者的HMG CoA还原酶抑制剂（他汀类药物）。
Cochrane Database Syst Rev. 2009 Apr 15(2):CD005019. doi: 10.1002/14651858.CD005019.pub3.
8
Systematic Review Reveals Lack of Causal Methodology Applied to Pooled Longitudinal Observational Infectious Disease Studies.系统评价揭示了在汇总的纵向观察性传染病研究中缺乏因果方法学的应用。
J Clin Epidemiol. 2022 May;145:29-38. doi: 10.1016/j.jclinepi.2022.01.008. Epub 2022 Jan 16.
9
Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study.他汀类药物用于HIV感染者心血管事件的一级预防：目标试验与模型研究。
BMJ Med. 2025 Apr 15;4(1):e001132. doi: 10.1136/bmjmed-2024-001132. eCollection 2025.
10
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.用于慢性肾病和糖尿病患者的胰高血糖素样肽1（GLP-1）受体激动剂。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.
本文引用的文献
1
Methodological Considerations to Enhance the Relevance of Causal Observational Research in the Field of Kidney Disease.提高因果观察性研究在肾脏疾病领域相关性的方法学考量
J Am Soc Nephrol. 2025 May 1;36(5):988. doi: 10.1681/ASN.0000000660. Epub 2025 Mar 13.
2
Long-Term Benefits and Safety of Statins in Patients with Kidney Failure: A Target Trial Emulation Study.他汀类药物对肾衰竭患者的长期益处及安全性：一项目标试验模拟研究
J Am Soc Nephrol. 2025 May 1;36(5):882-889. doi: 10.1681/ASN.0000000554. Epub 2024 Oct 31.
3
The Hong Kong Renal Registry: a recent update.香港肾脏注册处：近期更新
Hong Kong Med J. 2024 Aug;30(4):332-336. doi: 10.12809/hkmj2411504. Epub 2024 Aug 5.
4
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
5
Primary care clinician and community pharmacist perceptions of deprescribing.基层医疗临床医生和社区药剂师对减药的看法。
J Am Geriatr Soc. 2021 Jun;69(6):1686-1689. doi: 10.1111/jgs.17092. Epub 2021 Mar 10.
6
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.肾功能对基于他汀类药物的 LDL 胆固醇降低治疗效果的影响：来自 28 项随机试验的个体参与者数据的荟萃分析。
Lancet Diabetes Endocrinol. 2016 Oct;4(10):829-39. doi: 10.1016/S2213-8587(16)30156-5. Epub 2016 Jul 29.
7
Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease.观察性数据在比较有效性研究中的应用：他汀类药物随机试验与冠心病一级预防的模拟。
Stat Methods Med Res. 2013 Feb;22(1):70-96. doi: 10.1177/0962280211403603. Epub 2011 Oct 19.
Zotero 插件